For adenocarcinoma specifically, DM was observed in promoters [hypermethylated RASL12; SPTAN1, mir-26a, hypomethylated NQO1, SIRPB1, NF1A] and gene bodies [hypermethylated AKAP13, ANK family, PRKCE, ROS1; hypomethylated FAM171A1, PARK2, BCAS3, RHOJ] and many others. Here, PRKN is linked to adenocarcinoma.